Cube&Company Co. Ltd
Exergy21 Co., Ltd. manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea. It primarily provides active pharmaceutical ingredients. The company was formerly known as Hanchang Biotech Co., Ltd. and changed its name to Exergy21 Co., Ltd. in October 2022. Exergy21 Co., Ltd. was founded in 1999 and is headquartered in Seoul, South Korea.
Cube&Company Co. Ltd (043090) - Total Liabilities
Latest total liabilities as of December 2024: ₩12.58 Billion KRW
Based on the latest financial reports, Cube&Company Co. Ltd (043090) has total liabilities worth ₩12.58 Billion KRW as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cube&Company Co. Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Cube&Company Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cube&Company Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Cube&Company Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bayan Mining and Minerals Ltd
AU:BMM
|
Australia | AU$310.21K |
|
LM Funding America Inc
NASDAQ:LMFA
|
USA | $11.75 Million |
|
Tingo Group Inc.
NASDAQ:TIO
|
USA | $1.33 Billion |
|
Eguana Technologies Inc
OTCQB:EGTYF
|
USA | $49.94 Million |
|
ROCKWOOL INT. -B- (R90.SG)
STU:R90
|
Germany | €799.00 Million |
|
Avricore Health Inc
PINK:AVCRF
|
USA | $35.94K |
|
I&I Group Public Company Limited
BK:IIG
|
Thailand | ฿938.60 Million |
|
SNAP-ON - Dusseldorf Stock Exchang
DU:SPU
|
Germany | €2.46 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Cube&Company Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cube&Company Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cube&Company Co. Ltd (2011–2024)
The table below shows the annual total liabilities of Cube&Company Co. Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩12.58 Billion | -43.85% |
| 2023-12-31 | ₩22.41 Billion | +28.87% |
| 2022-12-31 | ₩17.39 Billion | -29.58% |
| 2021-12-31 | ₩24.69 Billion | +1153.43% |
| 2020-12-31 | ₩1.97 Billion | -69.08% |
| 2019-12-31 | ₩6.37 Billion | -4.29% |
| 2018-12-31 | ₩6.66 Billion | -43.50% |
| 2017-12-31 | ₩11.78 Billion | +19.81% |
| 2016-12-31 | ₩9.83 Billion | -31.42% |
| 2015-12-31 | ₩14.34 Billion | +10.52% |
| 2014-12-31 | ₩12.97 Billion | +18.53% |
| 2013-12-31 | ₩10.94 Billion | -22.62% |
| 2012-12-31 | ₩14.14 Billion | -37.52% |
| 2011-12-31 | ₩22.64 Billion | -- |